Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar 15;14(3):e238583.
doi: 10.1136/bcr-2020-238583.

Delayed miscarriage inside an infected decidual cast: a rare complication of the Depo medroxyprogesterone acetate injection

Affiliations
Case Reports

Delayed miscarriage inside an infected decidual cast: a rare complication of the Depo medroxyprogesterone acetate injection

Ryo Fukaura et al. BMJ Case Rep. .

Abstract

Decidualisation of the endometrium is a progesterone-mediated reaction that naturally occurs during a woman's menstrual cycle. The hyperproliferated tissue is then usually dissolved and passed in a menstrual period. Occasionally, the natural dissolution does not happen, and the tissue maintains the shape of the endometrium, forming a decidual cast. These casts are known to be formed secondary to the use and/or cessation of various contraceptive methods. Here, we report a case of a patient presenting with passage of a decidual cast secondary to cessation of the Depo medroxyprogesterone acetate injection. This is the first reported case of the cast becoming infected, and also the first case of a decidual cast containing old products of conception.

Keywords: contraception; obstetrics and gynaecology; pregnancy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
CT image taken in emergency department. We can see a mass in the endocervical canal.
Figure 2
Figure 2
Ultrasound image of the uterus after the patient had passed the mass. The uterus is empty.
Figure 3
Figure 3
Solid tissue passed per vagina by the patient.

Similar articles

References

    1. Westhoff C. Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety. Contraception 2003;68:75–87. 10.1016/S0010-7824(03)00136-7 - DOI - PubMed
    1. FSRH Clinical Effectiveness Unit . FSRH clinical guidance: Progesterone-only injectable 2014.
    1. Howard DL, Wayman R, Strickland JL. Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12 months of follow-up. J Pediatr Adolesc Gynecol 2013;26:358–65. 10.1016/j.jpag.2013.07.013 - DOI - PubMed
    1. Harel Z, Biro FM, Kollar LM, et al. . Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. J Adolesc Health 1996;19:118–23. 10.1016/1054-139X(95)00322-J - DOI - PubMed
    1. Polaneczky M, Liblanc M. Long-Term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. J Adolesc Health 1998;23:81–8. 10.1016/S1054-139X(98)00014-7 - DOI - PubMed

Publication types